Daily Practice Use of Bortezomib in Relapsed Refractory Multiple Myeloma: Safety Efficacy Results of a Compassionate Use Program in Switzerland. Swiss Med Wkly 2007, 137 (2122), 317-322. https://doi.org/10.4414/smw.2007.11716.